PTPMT1 regulates mitochondrial death through the SLC25A6-NDUFS2 axis in pancreatic cancer cells

Area of Science:

• Mitochondrial biology
• Cancer research
• Biochemistry

Background:

• Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer with limited treatment options.
• Mitochondrial proteins, like dual-specificity phosphatase PTPMT1, are often dysregulated in cancers.
• PTPMT1's role in PDAC pathogenesis requires further investigation.

Purpose of the Study:

• To investigate the function of PTPMT1 in pancreatic ductal adenocarcinoma.
• To determine if PTPMT1 is a viable therapeutic target for PDAC.

Main Methods:

• Pancreatic cancer cell lines were treated with siRNAs or the PTPMT1 inhibitor alexidine dihydrochloride.
• Cell viability, mitochondrial damage, and mitochondrial function were assessed.
• Co-immunoprecipitation was used to identify interacting proteins.

Main Results:

• PTPMT1 inhibition significantly reduced pancreatic cancer cell viability.
• Silencing PTPMT1 led to mitochondrial damage and impaired function.
• PTPMT1 was found to interact with SLC25A6 and NDUFS2, suggesting a role in mitochondrial regulation.

Conclusions:

• PTPMT1 plays a critical role in the viability and function of pancreatic cancer cells.
• The SLC25A6-NDUFS2 axis may be involved in PTPMT1-mediated mitochondrial regulation.
• PTPMT1 represents a promising therapeutic target for pancreatic ductal adenocarcinoma.